Frontlight ResearchEarly access
Trial site
Shuang-Ho Hospital
- 6running trials
- 2closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Chronic kidney disease2 trials
- Childhood cancers1 trial
- IgA nephropathy1 trial
- Parkinson disease1 trial
- Polycystic kidney disease1 trial
- Phase
- Phase 24 trials
- Phase 32 trials
- Status
- Active, not recruiting2 trials
- Completed2 trials
- Recruiting2 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Taipei Medical University Shuang Ho Hospital2 trials
- Academia Sinica, Taiwan1 trial
- Alpine Immune Sciences Inc, A Subsidiary of Vertex1 trial
- Genexine, Inc.1 trial
- HI-Bio, A Biogen Company1 trial
- and 2 more
Running trials
Recruiting
Aumolertinib Combined With Phased Chemotherapy for EGFR L858R Lung Adenocarcinoma
Active, not recruiting
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
Recruiting
Enrolling by invitation
Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease2 recruiting
- Lung cancer2 recruiting
- Polycystic kidney disease1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026